Apparent interference with extracorporeal membrane oxygenation by liposomal amphotericin B in a patient with disseminated blastomycosis receiving continuous renal replacement therapy-Reference-Cited by-同舟云学术

Apparent interference with extracorporeal membrane oxygenation by liposomal amphotericin B in a patient with disseminated blastomycosis receiving continuous renal replacement therapy

Published:2019-04-17 Issue:11 Volume:76 Page:810-813
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Branick Kaitlin¹,Taylor Matthew J¹,Trump Matthew W²,Wall Geoffrey C³

Affiliation:

1. Department of Internal Medicine, Iowa Methodist Medical Center, Des Moines, IA

2. Department of Pulmonary and Critical Care Medicine, The Iowa Clinic PC, and Department of Pulmonary and Critical Care Medicine—Unity Point Health, Des Moines, IA

3. Drake University College of Pharmacy and Health Sciences, Des Moines, IA

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/advance-article-pdf/doi/10.1093/ajhp/zxz054/28480151/zxz054.pdf

Reference12 articles.

1. Clinical characteristics and outcomes in patients with pulmonary blastomycosis;Kralt;Mycopathologia.,2009

2. Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America;Chapman;Clinical Infectious Diseases,2008

3. Amphotericin B formulations: a comparative review of efficacy and toxicity;Hamill;Drugs.,2013

4. Evaluation of altered drug pharmacokinetics in critically ill adults receiving extracorporeal membrane oxygenation;Ha;Pharmacotherapy.,2017